Suppr超能文献

14-3-3蛋白家族与精神分裂症

The 14-3-3 Protein Family and Schizophrenia.

作者信息

Navarrete Meaghan, Zhou Yi

机构信息

Department of Biomedical Sciences, Florida State University College of Medicine, Tallahassee, FL, United States.

出版信息

Front Mol Neurosci. 2022 Mar 14;15:857495. doi: 10.3389/fnmol.2022.857495. eCollection 2022.

Abstract

Schizophrenia is a debilitating mental disorder that affects approximately 1% of the world population, yet the disorder is not very well understood. The genetics of schizophrenia is very heterogenous, making it hard to pinpoint specific alterations that may cause the disorder. However, there is growing evidence from human studies suggesting a link between alterations in the 14-3-3 family and schizophrenia. The 14-3-3 proteins are abundantly expressed in the brain and are involved in many important cellular processes. Knockout of 14-3-3 proteins in mice has been shown to cause molecular, structural, and behavioral alterations associated with schizophrenia. Thus, 14-3-3 animal models allow for further exploration of the relationship between 14-3-3 and schizophrenia as well as the study of schizophrenia pathology. This review considers evidence from both human and animal model studies that implicate the 14-3-3 family in schizophrenia. In addition, possible mechanisms by which alterations in 14-3-3 proteins may contribute to schizophrenia-like phenotypes such as dopaminergic, glutamatergic, and cytoskeletal dysregulations are discussed.

摘要

精神分裂症是一种使人衰弱的精神障碍,影响着全球约1%的人口,但人们对这种疾病的了解并不深入。精神分裂症的遗传学非常复杂,难以确定可能导致该疾病的具体改变。然而,越来越多的人体研究证据表明,14-3-3家族的改变与精神分裂症之间存在联系。14-3-3蛋白在大脑中大量表达,并参与许多重要的细胞过程。在小鼠中敲除14-3-3蛋白已被证明会导致与精神分裂症相关的分子、结构和行为改变。因此,14-3-3动物模型有助于进一步探索14-3-3与精神分裂症之间的关系以及精神分裂症病理学研究。这篇综述考虑了来自人体和动物模型研究的证据,这些证据表明14-3-3家族与精神分裂症有关。此外,还讨论了14-3-3蛋白改变可能导致类似精神分裂症表型的潜在机制,如多巴胺能、谷氨酸能和细胞骨架失调。

相似文献

1
The 14-3-3 Protein Family and Schizophrenia.
Front Mol Neurosci. 2022 Mar 14;15:857495. doi: 10.3389/fnmol.2022.857495. eCollection 2022.
2
Animal models of schizophrenia.
Curr Top Behav Neurosci. 2010;4:391-433. doi: 10.1007/7854_2010_62.
4
Schizophrenia: What's Arc Got to Do with It?
Front Behav Neurosci. 2017 Sep 20;11:181. doi: 10.3389/fnbeh.2017.00181. eCollection 2017.
5
Genetic blockade of adenosine A2A receptors induces cognitive impairments and anatomical changes related to psychotic symptoms in mice.
Eur Neuropsychopharmacol. 2016 Jul;26(7):1227-40. doi: 10.1016/j.euroneuro.2016.04.003. Epub 2016 Apr 28.
6
Astrocytes in schizophrenia.
Brain Neurosci Adv. 2021 Apr 27;5:23982128211009148. doi: 10.1177/23982128211009148. eCollection 2021 Jan-Dec.
7
Disturbed Prefrontal Cortex Activity in the Absence of Schizophrenia-Like Behavioral Dysfunction in Deficient Mice.
J Neurosci. 2019 Oct 9;39(41):8149-8163. doi: 10.1523/JNEUROSCI.0623-19.2019. Epub 2019 Sep 5.
8
Emerging evidence for astrocyte dysfunction in schizophrenia.
Glia. 2022 Sep;70(9):1585-1604. doi: 10.1002/glia.24221. Epub 2022 May 30.
9
Inhibition of 14-3-3 Proteins Leads to Schizophrenia-Related Behavioral Phenotypes and Synaptic Defects in Mice.
Biol Psychiatry. 2015 Sep 15;78(6):386-95. doi: 10.1016/j.biopsych.2015.02.015. Epub 2015 Feb 19.
10
Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder.
Neuropharmacology. 2017 Jul 15;121:179-194. doi: 10.1016/j.neuropharm.2017.04.037. Epub 2017 Apr 26.

引用本文的文献

1
Fragment-Based Interrogation of the 14-3-3/TAZ Protein-Protein Interaction.
Biochemistry. 2024 Sep 3;63(17):2196-2206. doi: 10.1021/acs.biochem.4c00248. Epub 2024 Aug 22.
3
Modulating GPCR and 14-3-3 protein interactions: Prospects for CNS drug discovery.
Drug Discov Today. 2023 Aug;28(8):103641. doi: 10.1016/j.drudis.2023.103641. Epub 2023 May 24.
4
Exploring the Binding Mechanism of a Supramolecular Tweezer CLR01 to 14-3-3σ Protein Well-Tempered Metadynamics.
Front Chem. 2022 May 12;10:921695. doi: 10.3389/fchem.2022.921695. eCollection 2022.
5
Rho-Rho-Kinase Regulates Ras-ERK Signaling Through SynGAP1 for Dendritic Spine Morphology.
Neurochem Res. 2022 Sep;47(9):2757-2772. doi: 10.1007/s11064-022-03623-y. Epub 2022 May 27.

本文引用的文献

1
14-3-3 Dysfunction in Dorsal Hippocampus CA1 (dCA1) Induces Psychomotor Behavior a dCA1-Lateral Septum-Ventral Tegmental Area Pathway.
Front Mol Neurosci. 2022 Feb 14;15:817227. doi: 10.3389/fnmol.2022.817227. eCollection 2022.
2
14-3-3 proteins promote synaptic localization of N-methyl d-aspartate receptors (NMDARs) in mouse hippocampal and cortical neurons.
PLoS One. 2021 Dec 28;16(12):e0261791. doi: 10.1371/journal.pone.0261791. eCollection 2021.
3
Beyond Neuronal Microtubule Stabilization: MAP6 and CRMPS, Two Converging Stories.
Front Mol Neurosci. 2021 May 5;14:665693. doi: 10.3389/fnmol.2021.665693. eCollection 2021.
4
Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease.
Alzheimers Dement (Amst). 2021 May 1;13(1):e12179. doi: 10.1002/dad2.12179. eCollection 2021.
5
Clinical Use of Improved Diagnostic Testing for Detection of Prion Disease.
Viruses. 2021 Apr 28;13(5):789. doi: 10.3390/v13050789.
6
Inhibition of 14-3-3 Proteins Alters Neural Oscillations in Mice.
Front Neural Circuits. 2021 Mar 12;15:647856. doi: 10.3389/fncir.2021.647856. eCollection 2021.
7
Genetic architecture of schizophrenia: a review of major advancements.
Psychol Med. 2021 Oct;51(13):2168-2177. doi: 10.1017/S0033291720005334. Epub 2021 Feb 8.
8
Dysregulation of peripheral expression of the YWHA genes during conversion to psychosis.
Sci Rep. 2020 Jun 17;10(1):9863. doi: 10.1038/s41598-020-66901-1.
10
Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias.
Alzheimers Dement. 2020 Feb;16(2):262-272. doi: 10.1016/j.jalz.2019.09.001. Epub 2020 Jan 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验